Latest Cost Reduction Initiatives News

FOS Capital has completed a $1.55 million placement at $0.12 a share, giving the lighting and electrical services group fresh funding for growth initiatives. A further $310,000 director subscription remains subject to shareholder approval.

FOS Capital has secured firm commitments for a non-underwritten $1.86 million placement at $0.12 a share and will seek up to another $750,000 through a Share Purchase Plan. The raise will fund working capital, the Queensland Schools Lighting Upgrade Program, Aldridge Traffic Systems expansion and cost-reduction initiatives.

FOS Capital anticipates a sharp earnings turnaround in FY27, driven by cost cuts, a $10 million order book, and a record $130 million pipeline.

Alliance Aviation Services has launched the retail tranche of its fully underwritten $40 million equity raising, offering shareholders new shares at $0.70 each to reinforce its balance sheet and support ongoing turnaround efforts.

Prestal Holdings Limited posted a 30% drop in sales to $10.3 million and a $3.6 million net loss for FY26, while exiting its core Hampers With Bite business in a strategic pivot.

Alliance Aviation Services posted a statutory loss of $90.9 million in FY2026, driven by a $164.8 million impairment on its Fokker fleet, while underlying profit remained within guidance. The company is realigning around core FIFO operations, fleet renewal, and cost discipline, supported by a $40 million equity raise and revised Qantas wet lease terms.

Endeavour Group’s FY26 results show modest sales growth but a sharp profit decline due to $372 million in significant item expenses, alongside a strategic reset and climate commitments.

Excite Technology Services (ASX: EXT) has secured $3.122 million in sales over June and July 2026, bolstered by government contracts and private sector recurring revenue. The company is also tapping into a growing AI cybersecurity market with a pipeline exceeding $200,000.

ImpediMed reported a 3% revenue increase to $3.6 million in Q4 FY26, bolstered by a $15.3 million capital raise and strategic leadership hires as it pushes growth in cancer survivorship, heart health, and weight management.

The Star Entertainment Group reported a significant improvement in quarterly EBITDA loss alongside stable revenue, completing key joint venture exit and refinancing milestones that boosted liquidity to $267 million.

Microba Life Sciences has delivered robust FY26 growth in its core microbiome testing business, with revenues up 92% year-on-year and a new GI Navigator product set for launch in September 2026. The company also announced a $7 million annualised cost reduction program as it advances towards cashflow break-even.

TruScreen Group posted a NZ$2.25 million loss for FY2026, with its auditor highlighting material uncertainty over the company’s ability to continue without further funding. Revenue rose to NZ$2.4 million amid geographic expansion, but cash burn and accumulated losses remain significant.